Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.
The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...
Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.
Learn more about whether Globus Medical, Inc. or Inspire Medical Systems, Inc. is a better investment based on AAII's A+ ...
Learn more about whether Globus Medical, Inc. or iRhythm Technologies, Inc. is a better investment based on AAII's A+ ...
Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve ...
Buying $100 In GMED: If an investor had bought $100 of GMED stock 10 years ago, it would be worth $294.81 today based on a price of $75.50 for GMED at the time of writing.
Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in ...
AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of ...